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In the course of a comprehensive investigation of the mode of action and the 
biological activities  of human complement, it became necessary to isolate  the 
second component (C'2).  Recently,  accumulated  evidence indicated  that  C'2 
and  the  fourth  component  (C'4)  fulfill  their  function  in  the  complement 
reaction by forming a  bimolecular complex which  constitutes  the  activating 
enzyme for the third component (C'3) (1). Further verification of this concept 
required  that  C'2 and  C'4 were available  as purified proteins.  Since C'2 had 
not been isolated so far,  a  method for its purification was elaborated  and C'2 
was identified  and characterized as an individual protein.  To facilitate detec- 
tion of C'2 protein following its reactions with other complement components 
a  radioactive label was introduced into the purified protein and a  monospecifie 
antiserum  to  C'2  was  prepared.  With  these  tools  studies  were  initiated  to 
determine the fate of the C'2 molecule in the complement reaction. 
Materials and Methods 
Serum and Pseudoglobulin.--Human blood from four donors was allowed to clot for 4 hr 
and the clot was removed by centrifugation. The serum in a volume of approximately 800 ml 
was dialyzed for 48 hr against 3 X  10 liters of an 8 X  10  -3 M solution of Nas EDTA of pH 
5.4 and a conductance of 1.25 mi]llmhos/cm to precipitate the euglobulins. The pseudoglobulin 
fraction was separated from the euglobulin fraction by centrifugation twice at 4°C and 1500 g 
for 30 rain, then dialyzed overnight against phosphate buffer, pH 6.0, T/2 (ionic strength)  = 
0.06, containing 2 X 10  "-3 M  EDTA. This buffer, which had a conductance of 4.0 millimhos/cm 
win hereafter  be referred  to as "starting buffer."  A conductance  of 4.0 millimhos/cm was 
required  when  the capacity of the carboxymethyl  (CM)-celhilose was 0.7 meq/g. Even a 
slight change in absorbency for the cellulose necessitated  a  change in conductance  for the 
starting buffer (see below). 
Treatment of Pseudoglobubin with Diisopropylfluorophosphate (DFP).--The pseudoglobulin 
was incubated in a tightly stoppered Erlenmeyer flask at 37°C for 1 hr with DFP at a final 
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concentration of 10  -3 ~. The DFP was obtained as a  5 ~  solution. Before use it was diluted 
with an equal volume of anhydrous isopropyl alcohol, a measure designed to reduce the vola- 
tility of this highly toxic reagent (2). Despite this measure, great care was taken to ensure 
that following the period of incubation at 37°C, the flask was cooled to 0-4°C before it was 
unstoppered. 
CM-Cdlulose Ckromatograpky.--The  DFP-treated material was applied to a  7.5  X  60 cm 
column containing approximately 2000 ml of packed  CM-cellulose which had been equili- 
brated overnight with starting buffer. Following the application of the sample,  10 liters of 
starting buffer were passed through the column to remove proteins which, under these condi- 
tions, were not adsorbed to the CM-cellulose. C'2 together with other basic proteins were 
eluted by the application of a  salt gradient from 0-0.7 ~  sodium chloride. A  2 liter beaker 
which served as the mixing chamber and contained 2000 ml of starting buffer was connected 
by siphon to a  2 liter Erlenmeyer flask containing approximately 1900 ml of 0.7 x¢ NaCI in 
starting buffer. The flow rate was adjusted to 2 ral/min and 20-ml fractions were collected. 
The fractions containing C'2 hemolytic activity were pooled and concentrated to 20 ml by 
tfltrafdtmtion in an Amicon concentration device using a  UM 1 ultrafiiter. This sample was 
again treated with DFP as outlined above. 
It was found that the conductivity required for the starting butter was highly dependent 
on the capacity of the CM-ceilulose used. It was therefore necessary to establish the required 
conductivity of  the starting buffer for each new batch of CM-cellulose.  In a  prellmln~ry 
experiment the conductance of the starting buffer was lowered to 3.5 mli|imhos/cm and Ct2 
was elated by an NaC1 gradient in the usual manner. The conductivity was then determined 
at which the C~2 started to elate from the column, and in future experiments with the same 
batch of cellulose,  the conductance of the starting buffer was adjusted to be 0.5 mi111mhos/ 
cm below this figure. 
Pevikon Block ElecProphoresis.--The concentrated DFP-treated chromatography fraction 
was divided into two 10-ml samples, each of which was subjected to Pevikon block electro- 
phoresis by the method previously described  (3).  Phosphate buffer, pH  6.0,  T/2  --  0.05, 
containing 2.5 X  10  -~ g  EDTA was used. The polycinyl sheeting used for the base and cover 
of the block was washed with 5 X  10  -s g  EDTA before use. Electrophoresis was allowed to 
proceed for 23 hr at 4°C employing a potential gradient of 4 v/cm. 
Hydroxyl  A patite Chromatography.--Since commercially available OH-apatite was found 
to  give consistently very poor recovery of protein, hydroxyl apatite was used which was 
prepared following the method of Tiselius et al. (4). New batches of freshly prepared hydroxyl 
apatite also gave a very low recovery of C'2 hemolytic activity. However, by passing 200 mg 
of human serum albumin through the packed OH-apatite colnmn before application of the 
C'2 preparation, this problem was alleviated. It was found unnecessary to repeat this pro- 
eedure when the column was reused. The material from the two Pevikon blocks was con- 
tained in approximately 100 ml and this volume was applied to a  16 X  1.5 can col-ran of OH- 
apatite which had been equilibrated with phosphate buffer, pH 5.8, conductance 3 millimhos/ 
cm. Following application of the sample, the column was washed with 100 ml of the same 
buffer, followed by 250 ml of each of four buffers having the same pH but different conduc- 
tivities. The concentration of phosphate buffer was increased in a  step-wise manner to yield 
conductances of  12,  14,  16,  and  17  milllmhos/cm, respectively. Finally,  in  order  to elate 
residual protein, the column was washed with phosphate buffer having a  conductance of 68 
milllmhos/Cm. The flow rate of the column was adjusted to  1 ml/min and 4-ml fractions, 
were collected.  Since at this stage the protein concentration in the column effluent was low, 
it was necessary to use siliconized tubes for collection of the samples in order to preserve C'2 
activity. 
Concentration of Purified C'g.--The fractions cont~Linlng C'2 activity were pooled, and to 
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human serum albumin was added in an mount sufficient to yield 1 mg/ml in the concentrated 
pool. The final material was divided into 0.1  or 0.2 ml aliquots contained in 1 X  7 can sili- 
conized tubes and was frozen in liquid nitrogen and stored at -70°C until used. 
Preparation of Human Serum Albumin as Carrier Protein for Purified C'2.--1  g of crystal- 
lized human serum albumin  (Behringwerke AG, Marburg/Lahn,  Germany)  dissolved in 10 
ml of veronal buffer, pH 8.6,  T/2  =  0.05,  was subjected to Pevikon block electrophoresis 
for 16 hr. The peak fractions of the major component were pooled and treated overnight at 
4°C  with iodoaeetamide at a  fln~! concentration of  10  -2 M.  Following concentration,  this 
material was applied to a Sephadex G-100 column and the monomeric form of the iodoacetam- 
ide-treated albnmln was isolated and concentrated, 
Preparat,km of Complement  Components  and of Erythrocyte-Antibody-Complement Complexes. 
--Partially purified C'I was prepared in its macromolecuiar form according to Nelson  (5). 
The esterase moiety of the first component (6) was isolated according to Haines and Lepow 
(7). Highly purified C'3 and C'4 were isolated according to the methods previously described 
(8, 9). C'2 was oxidized by treating 1 vol of C'2 with an equal volume of 5 X  10  --6 M 12 in 
2.5 X  10"*  M KI, as  described  in detail  elsewhere  (i0).  The C'2 hemolytic activity  assay (I0) 
used in this  study and the preparation of the assay cells,  EAC'Ia, 4, have been described 
previously (11). 
Polyaorylamide Gel F.Jearopkoresis.--For disc  electrophoresis on  polyacrylamide gel  the 
method of Davis (12) was used, employing a concentration of acrylamide in the separating 
gel of 6%. 
In order to locate C'2 hemolytic activity to a protein band in the acrylamide gel, duplicate 
gels were employed. One was stained for protein and the other was cut into 2-ram segments 
each of which was transferred to a 1 X  7 cm tube containing 0.2 ml of phosphate buffer, pH 6 
and 0.005 x  EDTA. The gel segments were ground with a glass rod and after 1 hr of standing 
at 0°C, the tubes were centrifuged at 0°C for 30 rain and the supematants were removed with 
a  Pasteur pipette and  tested for C'2 hemolytic activity. In experiments in which C'2-L~I 
was u~,  the radioactivity of each gel segment was measured before extraction of the 
protein. 
Radioactive LabdJng of C'2.--C'2 was labeled with ~I  by the method of McConahey and 
Dixon (13). In order to preserve the hemolytic activity of C'2 during the labeling process it 
was found necessary to reduce the amount of the oxidizing agent, chloramlne T, to 5 #g/rag 
of protein.  Since the albumin which was used to stabilize and protect highly purified C'2 
was also labeled with radioactive iodine, it was necessary to replace the albumin3~I by non- 
radioactive albumin. The labeled preparation was extensively dialyzed against 2 X  10 liters 
of phosphate  buffer, pH 6.0,  T/2  =  0.1,  containing 0.005  x~ EDTA, followed by dialysis 
against  10 liters of the starting buffer used for CM-celluiose chromatography  (see above). 
The sample was then applied to CM-celluiose contained in a  10 nd pipette previously equili- 
brated with starting buffer. Under these conditions, the albumin-mI passed through the CM- 
cellulose, while the C'2-t~I was adsorbed, and after the albumin-mI had been washed from 
the column with starting buffer, the C'2-I~I was eluted by an NaCI gradient. The C'2-ml 
was collected into  siliconized tubes,  pooled and  concentrated  after  addition  of unlabeled, 
iodoace*amlde treated, monomeric albumin. To prepare  °xyc'2 from C'2-1~I, 2  X  10  -5 M 
Is in 1 X  I0  "-a M KI was employed. 
Sucrose Density Gradiont Ultracentrifugation.--Linear sucrose density gradients  (7-31%) 
were prepared with the Buchhr automatic density gradient device. Sucrose was dissolved in 
phosphate buffer, pH 6.0  T/2  =  0.1,  containing 0.1  u  NaCI. Ultracentrifugation was per- 
formed for 15 hr at 50,000 rpm and 4°C in a Spinco L-2 machine employing an SW 50 rotor. 
Fractions were collected using the Buchler gradient fractionation device. For s  rate deter- 
minations,  the  following reference substances  were  used:  human  "yG-globuiin-mI  (7S), 
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Gel Filtration.--For estimation of the diffusion coefficient of C'2, a 105 X  2.5 cm column, 
Sephadex G-200 and phosphate buffer, pH 6.0, T/2 =  0.1, containing 0.1 ~ NaCI were em- 
ployed. For application, the density of the sample was increased with NaC1 and layered be- 
tween the gel bed and the supernatant buffer.  1-ml fractions were collected.  As reference 
substances  with known diffusion coefficients were employed: human 3,G-globulin-181I (3.8 X 
10  -7 cm2/sec), human hemoglobin (6.8 X  10  -7 cm2/sec), and equine cytochrome C (13.0 X 
10  -7 cmVsec). 
Preparation of Sp~ific Antiserum ot Human C'2.--0.1 ml of a mixture containing equal 
volumes of the purified  C'2 preparation and Freund's complete adjuvant was injected into 
each popliteal lymph node of two rabbits, according to the method of Goudie et al. (14). 1 
month later 0.1 ml of a similar mixture was injected intramuscularly into each of two sites in 
the hindquarters of both rabbits. 6 days later the animals were bled and the antiserum was 
adsorbed with human serum albumin and 7G-globulin. 
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FIG. 1.  First step of C'2 purification: Elution from CM-cellulose. C'2 hemolytic activity 
together with 2-4%  of the pseudoglobulin  are eluted by an NaC1 concentration gradient 
started at tube 1.96-98% of the protein was washed through the column with the starting 
buffer  (not shown)  before  application of the gradient. Fractions 80-150  were  pooled  and 
concentrated for further separation by Pevikon block electrophoresis. 
RESULTS 
Essential  Measures for  Preservation  of C'2  Hemolytic  Activity  during  and 
after Purification.--Since  it was found that C'2 activity was most stable at pH 
6  and in the presence of EDTA, most manipulations were performed at these 
conditions.  Despite  these  measures,  substantial  inactivation  of  C'2  was  en- 
countered  during  CM-ceUulose  chromatography  and  Pevikon  block  electro- 
phoresis. On investigation, it was found  that  a  substance with  the ability to 
inactivate C'2  (and  C'4)  was present in the effluent from the CM column in 
some of the fractions containing Ct2 hemolytic activity (Fig. 1). On pooling the 
C'2-containing fractions,  this substance,  which is probably identical with C'I 
esterase, was introduced into the preparation and caused  inactivation of CP2 
encountered  at  this stage and  during  the subsequent  concentration  step and 
Pevikon block electrophoresis. The C'2 which was recovered from the Pevikon 
block  in  hemolytically  active  form  remained  stable  throughout  periods  of MARGARET  J.  POLLEY  AND  HANS  J.  MULLER-EBERHARD  537 
storage  of  several months.  It was  therefore  concluded that  the  inactivating 
enzyme was separated from the C'2 by electrophoresis. Since,  like C'I esterase 
(6),  this  enzyme was inactivated by DFP, both  the pseudoglobulin and  the 
C'2 pool from the  CM-ceUulose column were  subjected  to  DFP  treatment. 
Subsequent  to  the  introduction  of  this  measure  no inactivation  of  C'2  has 
occurred during the isolation procedure. 
In the final purification step C'2 is obtained in a concentration of 5-10 pg/ml. 
Concentration of this dilute protein solution by ultrafiltration pressure dialysis 
or lyophilization resulted in total loss of the C'2 hemolytic activity. Inactivation 
TABLE I 













OH-apatite (concentrated)  I 
r,,d  mg 
720  78,000 
710  69,000 
530  1,380 
11.5  1,400 
137  13.8 
6  2.88 
Whole serum  840  72,000 
Pseudoglobulin  820  59,000 
CM-efltuent (unconcen-  850  2,720 
trated) 
CM-eittuent (concen-  19  2,600 
trated) 
Pevikon block  311  25 
OH-apatite (concert-  6  2.5 
trated) 
Effective  molecules 
(1.3  X  1014) 
(1.42 X 1014) 
4.2  X 10  x3 
2.6  X  1013 
1.3  X 1013 
5.6  X 1012 
(1.18 X  1014) 
(1.15 X  1014) 
3.4  X  10  t3 
Specific hemolytic 
activity 
2.45 X 10  :~ 
3.5  X  101~ 
3.51 X 1012 
(eft.  mol./pg) 
(1.67 X  106) 
(2.06  X  106) 
3.04  X  107 
1.86 X  107 
9.4  X  108 
1.94 X  109 
(1.64 X  106) 
(1.95 X  106) 
1.26 X  10  T 
9.4  X  10  e 
1.4  X  10  s 
1.4  X  10  g 
* Based on Folin method. 
was  attributed  to denaturation  of C'2 in dilute  solution.  Concentration was 
therefore  attempted  in  the presence of a  carrier.  Both pressure  dialysis  and 
lyophilization in  the  presence of  10  -~ u  glycine resulted  in  90 %  loss of the 
hemolytic activity. However, no loss of activity was encountered when C'2 was 
concentrated by pressure dialysis in the presence of human serum albumin.  As 
the material was to be tested for purity on polyacrylamide gels,  and  as  the 
polymeric form of albumin migrated more slowly than the monomer and could 
obscure  contaminants  in  the  C'2  preparation,  the  monomeric form  of  the 
carboxymethylated  albumin  was  isolated  and  then  used  in  all  subsequent 
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Partial Purification of C'2 by CM-Cellulose Chromatography and Preparative 
Electrophoresis.--Under  the  conditions  employed,  only  2-4%  of  the  DFP- 
treated pseudoglobulin applied to the CM-cellulose  column was adsorbed, the 
remaining 96-98% was washed through by the starting buffer. The adsorbed 
protein was eluted by a salt concentration gradient (Fig. 1). In terms of protein, 
a 30-fold purification was thus achieved which, however, was accompanied by 
a three- to fourfold loss of hemolytic activity as measured by effective molecule 
titration (Table I). 
The material from the CM-ceUulose column which contained C'2 activity was 
concentrated and further separated by Pevikon block electrophoresis.  At pH 
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6,  C'2  migrated  towards the anode together with  contaminating/3-globulins 
such as C'3, C'4, and C'5. */-Globulin which represented 99% of the material 
moved towards the cathode (Fig.  2). While 2 g of protein was applied to two 
Pevikon  blocks,  approximately  20  mg  of  protein  was  recovered  from  the 
/~-globulin region which contained C'2 hemolytic activity. 
Final  Purification of  C'2  by  Hydroxyl  Apatite  Chromatography.--Many 
different methods were explored,  such  as:  chromatography  on  CM-cellulose 
and  TEAE-ceUulose; gel  filtration  on  Sephadex  G-200;  preparative  electro- 
phoresis on polyacrylamide gel and  agar;  hydroxyl apatite  chromatography 
under alkaline conditions.  None of these methods proved entirely satisfactory, 
since only partial purification resulted from each. Finally, the method selected 
which resulted in total purification of C'2 and its identification as a  discrete 
serum protein was chromatography on hydroxyl apatite under acid conditions, 
using a stepwise elution procedure. 
Fro. 2.  Second  step  of  C'2  purification:  Pevikon  block  electrophoresis  performed  in 
phosphate buffer, pH 6, T/2 =  0.05, containing 2.5 X  10  -8 M EDTA. Origin is indicated by 
the arrow; the anode is to the right. Fractions 15-19 were pooled for further separation by 
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At pH 5.8, C'2 was eluted from the column at 16 millimhos/cm and emerged 
as a discrete protein peak which corresponded with the peak of Ct2 hemolytic 
activity  (Fig. 3). With  some batches of hydroxyl apatite, C'2 was eluted from 
the column at  15  millimhos/cm. In such cases, a  similar elution  pattern  was 
obtained when the buffers with conductances of 14 and 16 millimhos/cm were 
substituted by buffers having conductances of  13.2 and  15  millimhos/cm, re- 
spectively. 
Identification  of  C'2  with  a  Discrete  Serum  Protein.--On  analysis  of  the 
purified  C'2  by  polyacrylamide gel  electrophoresis,  two  protein  bands  were 
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FIG.  3.  Final step of C'2 purification:  Chromatographic  separation on hydroxyl apafite. 
The protein (fractions 15-19, Fig. 2) was applied in phosphate buffer, pH 5.8, 3 millimhos, and 
was eluted stepwise by buffers of increasing phosphate concentration. The first peak shown 
was eluted at 12 millimhos and the arrows mark the start of each successive step. Fractions 
54-66 were concentrated in the presence of human serum albumin (see text). 
close to each other. C'2 hemolytic activity recovered from the gel corresponded 
exactly to the major, more slowly migrating protein disc (Fig. 4). There was no 
hemolytic activity associated with  the minor and somewhat faster migrating 
component. As will be shown below (Fig.  10),  inactivation of the isolated C'2 
by C'I esterase resulted  in  complete disappearance of the  protein band  cor- 
responding to hemolytically active C~2. The inactive protein,  C/2i,  appeared as 
a single disc in a  more anodal position which corresponded directly to that of 
the minor component present  in untreated  CI2.  This  observation,  as well as 
immunochemical analyses (see below) indicated  that the minor component in 
purified C'2 constitutes C'2i and not an unrelated contaminant. The proportion 
of C'2i present in each of 10 preparations of C~2 varied between 5 and 50 %  of 
the  total protein.  In each case,  treatment with  C'I esterase resulted in  total 540  SECOND  COMPONENT  OF  HUMAN  COMPLEMENT 
conversion of the  active Ct2  protein to  the inactive, faster migrating product, 
C~2i. 
Correlation between C'2 Hemolytic  Activity  and C'2-t25I Prolein.--Under  the 
conditions employed for radioactive labeling, uptake of 12~I by C'2 was low, not 
FIG. 4.  Correlation between C'2 hemolytic activity and protein upon polyacrylamide gel 
electrophoresis.  Anode  is  towards  the  right.  Duplicate  gels  were  employed,  one  was 
stained  for  protein,  the  other was  analyzed  for  C'2  hemolytic activity.  Protein  bands 
in segments  13, 14, 18, and 19 represent  the carrier protein, human serum albumin (see Fig. 
10). 
OD70o  o. 
1.2t 
1.01 i  "  I  0D541  i]  [:  A---.A 
0.08  0.4 
0.06  il¢,  i?.!  to.3  
i  o.o,  ',It,  I/,  ',.  lo= 
10  20  t  3'0  40 
Tube Number 
E 
FIG. 5.  Chromatographic  separation  of  albumin-a25I from  C'2-x25I, and  correlation  of 
C'2 protein, hemolytic activity, and radioactive label. The arrow  marks application of the 
NaC1 concentration  gradient. Fractions 31-34 were pooled and concentrated in the presence 
of unlabeled human serum albumin. 
exceeding  0.6%.  The  specific  radioactivity  was  between  10,000  and  13,000 
cpm/#g. That the label was definitely incorporated into C'2 was shown by two 
different  methods.  Chromatography  of  the  carrier  albumin  purified  C'2 
mixture on CM-cellulose revealed an excellent correlation between the distribu- 
tions of Ct2  hemolytic activity, C'2 protein, and radioactivity (Fig. 5).  When MARGARET  J.  POLLEY  AND  HANS  J.  MULLER-EBERHARD  541 
Ct2-12~I, following separation from albumin-125I,  was  subjected  to  polyacryl- 
amide gel electrophoresis, radioactivity was found to be associated with both 
protein bands. The major peak of radioactivity was contained in the segment 
from which the hemolytically active C'2 was eluted. Following treatment of the 
labeled  preparation  with  C'I  esterase,  loss  of  C'2  hemolytic  activity  was 
associated  with  a  characteristic  shift  of  the  radioactivity peak  to  the  more 
anodal position of Ct2i. 
Yield and Specific Hemolytic Activity  of Purified  C'2.--As  can be seen from 
the values listed in Table I, the yield of C'2 in terms of effective molecules (15) 
was 3-4 % and in terms of protein approximately 0.0035 %. Hence, there was a 
1000-fold increase in activity-protein ratio. From this figure as well as from the 
recovery data it may be inferred that the concentration of C'2 in whole human 
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Fio.  6.  Dose  response  for  highly purified  C~2:  Average  number  of  C'2a  sites  per  cell 
(--ln(1  -- y)) versus nanograms of C'2. 
70/zg/ml. This figure must be regarded as a maximal estimate, the true value 
being probably lower than this. The uncertainty stems from the consideration 
that  effective molecule titrations  of C'2 in whole  serum may be falsely high 
since other complement components present in serum are likely to enhance the 
hemolytic  assay  system.  Secondly,  the  variable  proportion  of  C'2i  in  the 
preparations  tends  to  decrease  the  activity-protein  ratio  of  purified  C'2. 
Therefore,  the  true  degree  of  purification  achieved  in  the  isolation  of  C'2 
might be two or three times greater than indicated  in Table I, and  thus  the 
true serum concentration of C'2 only half or one-third of the calculated value, 
probably in  the  range of 15-30 pg/ml. 
With  isolated  C'2 it  became possible to  determine  directly  the number of 
C'2 molecules needed  to produce  one "effective molecule" in the sense of the 
one-hit  theory  of immune hemolysis  (16).  A  typical dose  response  curve  is 
shown in Fig. 6, where the amount of C'2 is expressed in absolute  weight units 
and where per cent hemolysis was converted to the negative natural  logarithm 
of the fraction of unlysed cells,  i.e.  --ln(1 -- y); y  being the fraction of  cells 542  SECOND  COMPONENT OF  HUMAN  COMPLEMENT 
which were lysed. In three experiments, each  using a  different preparation of 
C'2, it was found that an average of 1000 C'2 molecules equals  one "effective 
molecule;" i.e.,  the hemolytic  efficiency of C'2  is  approximately 0.1%.  It  is 
emphasized  that  these  calculations  are based  on  the  C12  protein which  was 
fully convertible by C'I esterase. 
Molecular  Weight Determination.--For the determination of the sedimenta- 
tion  coefficient,  C'2-125I was  subjected  to  ultracentrifugation  in  a  sucrose 
density gradient.  Using  three reference proteins  (Fig.  7)  the  sedimentation 
velocity of C~2 was found to be 5.2S. The diffusion coefficient (D) was estimated 
by gel filtration on Sephadex G-200 according to the method of Andrews (17). 
Using  the  same  three reference proteins  (Fig.  8),  the  diffusion coefficient of 
G  Hb  Cyt.C 
]1¢_ 
~--  Untreated C'2  ~'~ 
N2 
e~ 
10  2"O  3"0  '~0  5"0  6-0 
Fraction Number 
FIG.  7.  Comparative ultracentrifugal analysis of  C'2  and  C'2 following treatment with 
Crl esterase for 30 rain at 37°C, performed in a 7-31% sucrose density gradient in phosphate 
buffer, pH 6, T/2  =  0.1,  containing 0.1 ~t NaCI; for 16 hr at 50,000  rpm. As reference sub- 
stances were  used:  human 7G-globulin  (3'G); human hemoglobin  (Hb);  and  equine cyto- 
chrome C.  (Cyt. C). Sedimentation is toward the left. 
C'2 was found to be 4.0 X  10  -7 cm2/sec. Assuming the partial specific volume 
of  C'2  to be 0.73  and  utilizing  the  above recorded values for s  and  D,  the 
molecular weight of C'2 was calculated to be 117,000,  and the frictional ratio 
(18)  to  be  1.6.  Both the ultracentrifugal and filtration analyses of untreated 
Cr2  revealed  a  second,  minor  component which  apparently  was  of  smaller 
molecular size than the main component 
Immunochemical  Studies of Purified  C'2 and of C'2 in Serum.--Purified  C'2 
gave  a  strong  positive  reaction  in  Ouchterlony  plates  with  anti-C/2,  and 
negative  reactions  with  anti-C'3,  anti-C14,  and  anti-CtS.  Tests  with  anti- 
transferrin  and  antihemopexin  were  also  negative.  However,  an  anti~'G- 
globulin produced a weak precipitin reaction  in the immediate vicinity of the 
antigen well, indicating the presence of a small amount of 3,G-globulin. 
On immunoelectrophoretic analysis purified C'2  reacted only with anti-C~2: 
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FIc.  8.  Elution  patterns  obtained  following gel filtration  of  C'2  on  a  Sephadex  G-200 
column  (105 X  2.5  cm).  The upper pattern  shows untreated  CP2; the lower, CP2 following 
treatment with Cq  esterase for 30 rain at 37°C.  The columns were equilibrated with phos- 
phate buffer, pH 6, T/2  =  0.1, containing 0.1 M NaCl. Each sample contained three reference 
substances:  human  ~/G-globulin  (')G); human  hemoglobin  (Hb); and  equine cytochrome C 
(Cyt. C). 
FIC.  9.  Immunoelectrophoretic analysis of C'2 (upper well)  and  C'2 following treatment 
for 30 min at  37°C  with C'1 esterase  (lower well).  Antibody produced against purified C'2 
is in the center trough. Anode is to the right. 544  SECOND  COMPONENT  OF  HUMAN  COMPLEMENT 
as a  3-globulin, as was  expected on the basis of its mobility on block electro- 
phoresis. However, in agar its mobility was much  increased and only slightly 
smaller than that of albumin.  This differential behavior of C'2 in dependence 
of the type of gel used was highly reproducible. C'2 hemolytic activity could be 
eluted from agar as well as from agarose slides and its distribution corresponded 
in both media exactly to that of the C'2 precipitin arc. 
FIG. 10.  Comparative polyacrylamide gel  electrophoresis  analysis of untreated C'2 and 
C'2 following incubation with C'I esterase for 30 rain at 37°C. Also shown are analyses of Crl 
esterase alone and of the carrier protein, human serum albumin. Anode is towards the bottom. MARGARET  J.  POLLEY  AND  HANS  J.  MULLER-EBERHARD  545 
When whole serum was subjected to electrophoresis in agar,  the mobility of 
Ct2 was reduced  to that of a fast/3-globulin.  The same reduction in mobility 
was  observed with  purified  C'2  following the  addition  of  purified  C'4.  It is 
suggested, therefore, that the slower mobility of C'2 on agar electrophoresis of 
serum  is  due  to  the  previously demonstrated  reversible  complex formation 
between C'2 and C'4 (1). 
Effect of C1 Esterase on Purified C2.--Treatment of C'2 with C~I  esterase 
for 30  min  at  37°C  results  in  marked physicochemical alteration  of  the  C'2 
molecule which  coincides  with  loss of its hemolytic activity.  Compared with 
native C'2 the inactive reaction product C'2i moves more slowly on agar  gel 
electrophoresis and immunoelectrophoresis shows the C~2i arc to be wider than 
the  C'2  arc,  indicating  either  greater  diffusibility  or  electrophoretic  hetero- 
geneity of the product (Fig. 9). 
As  shown  in  Fig.  10,  disc  electrophoresis  revealed  C'2i  in  a  more  anodal 
position than untreated  C'2.  It also demonstrated clearly that all native C'2 
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* Mean of five  experiments. 
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molecules are susceptible to the action of C'I esterase and can be converted to 
C'2i.  That  the  faster  migrating,  minor  component  present  in  purified  C'2 
(Figs. 4 and 10) represents C'2i was demonstrated immunochemically. Prepara- 
tions which contained this component also showed the slow conversion product 
on immunoelectrophoresis. When unstained polyacrylamide gels were embedded 
into agar and then analyzed with anti-C'2 by diffusion in agar gel, a bimodal 
precipitin line was seen with untreated,  purified C'2, clearly showing that the 
minor component was antigenically closely related to the major protein com- 
ponent. 
Although  yielding  only one  single  disc  on  polyacrylamide electrophoresis, 
C'I esterase-produced  C'2i was found to be heterogeneous by both ultracen- 
trifugation  (Fig.  7)  and gel filtration  (Fig.  8).  For these experiments C'2-1~5I 
was used. The major component in C'2i had  an s  rate  of 4.5  and  a  diffusion 
coefficient of 4.9  X  10  -7 cm2/sec and therefore a  calculated molecular weight 
of 84,000  and  a  frictional  ratio of  1.4.  In  two  additional  analyses molecular 
weights of 82,000  and 81,000  were obtained.  Comparing these values with the 
molecular  parameters  of  untreated  C'2  (Table  II)  they  indicate  that  C'I 
esterase effects fragmentation of the C'2 molecule. 546  SECOND  COMPONENT  OF  HUMAN  COMPLEMENT 
Demonstration of the Physical Incorporation of C'2-12~I into C'3 Convertase -- 
On  the basis of molecular weight determinations it was previously postulated 
that the enzyme C'3 convertase is a  protein-protein complex which is derived 
from C'2 and C'4 (1). Utilizing C~2-125I this concept could be further examined. 
The  enzyme  was  generated  from  C'2-I25I  and  monomeric  C'4i  (19)  by  the 
action of C'I  esterase essentially as outlined before (1).  The reaction mixture 
C,2-1251+C,1  Est.  f~ 
~G  /~,  Cyt C 
% 
x 
Era.  ........ 
~a 
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FIG. 11.  Demonstration of incorporation of C'2 into C~3 convertase by sucrose density 
gradient ultracentrifugation: C~2-12aI treated with CI1 esterase  in the absence  (upper)  and 
presence  (lower) of C'4i.  Ultracentrifugation performed  under identical conditions to those 
described in the legend to Fig. 7. Human "gG-globulln ()G) and equine cytochrome  C  (Cyt. 
C) were used as reference substances. C'4i was quantitated by the distance between the antigen 
well and the precipitin arc formed with anti-Cr4 when tested by Ouchterlony  analysis. C~3 
convertase activity was determined by conversion of C~3 to C'3i. 
was  then  subjected  to  sucrose  density  gradient  ultracentrifugation  and  the 
distribution of radioactivity was  compared with  that observed in  the control 
which  consisted  of  C~2-125I treated  with  C'I  esterase  in  the  absence  of  C~4i. 
The results are depicted in Fig. 11.  A  fast sedimenting radioactivity peak was 
observed which corresponded exactly to the position of C~3 convertase activity 
and  which  was  not  seen  in  the  control  that  lacked  C'3  convertase  activity. 
There was also a small proportion of C'4i which sedimented faster than the bulk 
of C~4i  and  this material too was  distributed in  the  region of C'3  convertase MARGARET J.  POLLEY  AND  HANS  J.  M~LLERoEBERHARD  547 
activity. As expected, the main portion of C~2-1~5I sedimented after the reaction 
as unbound CJ2i with an s rate of 4.5S. This experiment constitutes a direct 
physical demonstration  of the incorporation  of the  C'2 molecule,  or  a  part 
thereof, into the enzyme C'3 convertase. 
DISCUSSION 
The second component of human complement is a trace constituent of serum 
which in the past has escaped detection as a protein, being recognized  solely 
through  its  biological  activity.  The  present  paper  gives  the  first  detailed 
description of a method which permits isolation of C J2 from human serum in a 
high degree of purity and in hemolytically active form. This method has been 
elaborated, modified and tested in this laboratory during the past 3 yr and has 
been found to produce preparations  of consistent quality. In absolute terms 
the yield of purified C J2 is low, however, if it is assumed, as is probable, that 
the serum concentration  of C~2 is  approximately 20/~g/ml,  the recovery is 
greater than 10%. 
Purification of human C~2 has been reported in abstract form by Lepow et 
al. (20), simultaneous with the first brief report on the subject from this labora- 
tory  (21).  Since  no further  account has been rendered  by these workers,  a 
comparison of the two methods and of the purity of the final products is not 
possible. Guinea pig C~2 has been functionally purified by Borsos et al. (22) and 
by Nelson et al.  (5).  Although  a  useful reagent,  functionally pure C~2 may 
consist of a mixture of many serum proteins as revealed by immunochemical 
analysis (23).  Employing an as yet unpublished biological  procedure, Mayer 
(23) apparently achieved a very high degree of purification of guinea pig C'2. 
Exploiting the specific affinity of Ct2 for Ct4, he first adsorbed C~2 from serum 
to EACh4 cells at low ionic strength and then eluted it from the cells at physi- 
ological ionic strength. 
Using the C~2 purified according to the method described in this paper, it 
was possible to characterize Ct2 by disc electrophoresis  as a discrete protein: 
C'2 activity corresponded to a single, well-defined protein band and, as theo- 
retically required, this protein was  totally  convertible by  C~I  esterase,  the 
converting enzyme of C~2. As anticipated,  the specific hemolytic activity of 
purified  C~2 was very high,  1 #g contained 2 X  109 effective molecules. Never° 
theless,  approximately 1000 potentially effective C~2 molecules  were required 
to produce one hemolytically effective,  or site-forming  molecule.  This relative 
inefficiency has been found to be an inherent feature of the C~2 reaction mecha- 
nism as has been reported separately (24). 
Monospecific antiserum to C~2 was produced by injecting minute amounts 
of purified protein directly into the popliteal lymph nodes of rabbits. In Ouch- 
terlony plates this antiserum detects only one protein in whole human serum 
which is immunologically identical with purified C~2. Since the antioCh2 anti- 548  SECOND  COMPONENT  O:F  HUMAN  COMPLEMENT 
body was present neither in several potent antisera to whole human serum nor 
in a variety of specific anfisera to known serum proteins,  it may be concluded 
that the protein described  in this communication is distinct from previously 
recorded  serum  constituents.  The  immunochemical  definition  of  C~2  with 
monospecific anti-C~2 has assumed  special significance in analyzing the bio- 
chemical defect of genetically C'2-deficient  individuals.  These studies  will be 
reported elsewhere.  1 
Incorporation of radioactive iodine  into the C'2  molecule without loss of 
hemolytic activity afforded working with amounts too small to be measured 
reliably by chemical  analysis.  The  radioactive label  as well as  the specific 
antibody made possible the detection of hemolytically inactive C'2  and thus 
an analysis of the fate of C'2  in its reaction with C'I  esterase and Ct4. Ad- 
mittedly, these latter studies are very incomplete, as they have been hampered 
by lack of sufficient material. Nevertheless, it has been possible to demonstrate 
clearly by four different methods (ultracentrifugation, gel filtration, disc and 
immunoelectrophoresis)  that  C'2  undergoes  characteristic  physicochemical 
changes when acted upon by C'I esterase. These experiments  suggest that in 
addition to changes in electric charge, there occurs a reduction in molecular size; 
i.e., fragmentation of the molecule. Molecular weight estimates of native and 
C'I  esterase-treated C'2  consistently revealed  a  difference of approximately 
35,000. Yet three replicate experiments failed to give convincing evidence for a 
fragment of this size (Figs. 7 and 8). In addition to the 83,000 molecular weight 
component,  the esterase-treated C~2 contained a small amount of heavier ma- 
terial which must have arisen by aggregation.  The possibility  was considered 
that the aggregates  were derived  from the lighter fragment. However,  in a 
fourth  experiment  with  CPl  esterase-treated  C~2, the  aggregates  were  not 
observed  (Fig.  11). It  is  also  conceivable  that  the  postulated fragment is 
obscured by the larger fragment from which it did not separate sufficiently in 
these experiments.  Or it might be derived from a region of the Ct2 molecule 
which does not become labeled with iodine. Since all experiments  were carried 
out with C'2-~5I, it would  thus escape detection. Further work is needed  to 
clarify the C'1 esterase effect. 
Taking a different methodological approach to this problem, Mayer and his 
colleagues (25-27) working with guinea pig C'2 arrived at conclusions similar 
to those drawn from the  above  presented results.  These workers  produced 
antiserum to a chromatographic fraction of guinea pig serum containing C'2. 
By absorption with complement-cell intermediate complexes they rendered it 
suitable for the detection of active and inactive C'2 by neutralization competi- 
tion. With this immunochemical  tool they found C"2 to be physically present 
on EAC'la,4,2a and to be released from this complex with its decay to the 
EAC'la,4 state. Since the released C'2 was of smaller molecular size than native 
1 Poiley, M. J. 1968.  Inherited C'2  deficiency in man. Lack  of  immunochemically detec- 
table C'2 protein in serum from deficient individuals. Sdence.  In press. MARGARET J.  POLLEY  AND  HANS  J.  MTj-LLER-EBERtIARD  549 
C'2,  they postulated cleavage of C'2 by cell-bound C'I as a necessary step in 
C'2 uptake. 
Perhaps the most significant aspect of the present work is the direct demon- 
stration of the incorporation of C'2 into the complement enzyme C'3 convertase. 
This enzyme, which cleaves C'3, has previously been shown to be derived from 
C'2 and C'4 by the action of C'I esterase (1). Since the molecular weight of the 
enzyme (305,000) was distinctly larger  than the molecular  weights  of either 
C'2 (115,000) or C'4 (229,000), it was postulated that the activity was resident 
in a C'2-C'4 protein-protein complex. However, since the molecular size of the 
enzyme was by 39,000 smaller than the sum of the molecular weights of the two 
precursors, it was further postulated that only a fragment of the C'2 molecule 
becomes  complexed  to  C'4.  The size of this fragment was  estimated to be 
approximately 76,000. This is very close indeed to the value found in this study 
for the molecular weight of the main component of C'I esterase--converted C'2. 
Moreover,  when radioactively labeled  C'2  was utilized for generation of C'3 
convertase  approximately 10 % of the labeled material sedimented on density 
gradient ultracentrifugation together with the C'3  convertase  activity peak. 
Thus the concept regarding  the formation of C'3  convertase  previously ad- 
vanced from this laboratory (1) is further supported by the results of this study: 
This enzyme is apparently unique in that it is formed from two distinct pre- 
cursor  proteins,  each being  totally devoid of enzymatic activity. Activity is 
generated by the action of another enzyme, C'I esterase,  on both precursors, 
but not by C'I esterase action on either precursor individually. Apparently the 
activity depends on the joining of a fragment of C'2 (F(a)C'2) in its nascent 
state to C'I esterase modified C'4 according to: 
C'4  c'l esterase > C'4i 
C'2  C'1 esterase )  F(a)C'2* +  F(b)C'2 
F(a)C'2* +  C'4i  Mg++  ~  C'(4i, 2)a(C'3 converts) 
Where F(a)C'2* denotes a transient state of activation of the F(a) fragment of 
C'2  and where F(b)C'2 is a postulated, not yet verified, smaller fragment of 
C'2. With purified C'2 available it will now be possible to determine the chem- 
ical nature of the C'2 cleavage, the type of bond which holds the active enzyme 
together,  and the effect of oxidation on C'2  (10) which  leads  to a  marked 
increase of activity and stability of the C~4,2a complex. 
SUMMARY 
A method has been described  for  the purification  and isolation  of the second 
component of complement  (C~2) from human  serum. The  protein is a ~1- 
globulin with an approximate molecular weight of I17,000.  Immunochemical 
analysis using a variety of specific antisera, including a monospecific antiserum 550  SECOND  COMPONENT  OF  HUMAN  COMPLEMENT 
to the isolated protein,  indicate  that  the  C'2 protein represents  a  heretofore 
unrecognized  human  serum  constituent.  Isolated  C'2  contained  2  X  109 
"effective molecules" per microgram and  1000 hemolytically active C'2 mole- 
cules  were  required  to  produce  a  single  hemolytically effective  Cr2  site  on 
erythrocytes  undergoing  immune  cytolysis.  C'I  esterase  treatment  of  C'2 
resulted in reduction of both its electrophoretic mobility and its molecular size, 
the latter observation indicating fragmentation of the molecule. Direct evidence 
was presented for the physical presence of C'2 as an integral part of the enzyme 
C'3 convertase. 
The authors wish to thank Miss Judy Rebol, Mrs. Karen Sharp, Mrs. Ann Seavey, and 
Mrs. Linda Wrighton for ~killful technical assistance. 
Adderdum.--Most of the commercially available batches of diisopropylfluorophos" 
phate (DFP) were found to be partially hydrolyzed and  therefore not suited for use 
in  the isolation of C'2. Highly reactive DFP was obtained from Boots of Notting- 
ham, England. 
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